Study of lymphoma changes over time in follicular lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how follicular lymphoma cells change (“clonal evolution”) over time. It may help doctors understand disease behavior and guide better future treatments, especially when people may need treatment soon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed follicular lymphoma (grades 1–2 or grade 3a) based on pathology review.
- You can provide enough stored biopsy tissue from diagnosis, or you may be able to repeat a biopsy if needed and your team thinks it’s safe.
- Your scans show lymphoma that can be measured or assessed on CT or FDG-PET, either from scans now or from scans done after diagnosis.
- You are 18 or older.
- You are well enough to take part (ECOG less than 2, roughly meaning you can do most daily activities).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks people with follicular lymphoma to share their experiences during treatment. It's not testing a new drug—it's collecting information to help improve care.
This study collects blood and tumor tissue samples from people newly diagnosed with aggressive non-Hodgkin lymphoma who will receive standard chemotherapy. The goal is to improve future tests for detecting minimal residual disease (tiny amounts of cancer left after treatment).
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This study follows people with Hodgkin or non-Hodgkin lymphoma who need strong treatment to try to cure their cancer. The goal is to learn more about how the disease and its treatment affect patients over time.
This study follows people newly diagnosed with chronic lymphocytic leukemia (CLL), a type of blood cancer, to learn more about the disease and how it progresses. By participating, you help researchers understand CLL better, which may improve future treatments.
This study looks at how changes in the MYC gene affect the outlook for people with certain fast-growing lymphomas, including diffuse large B-cell lymphoma and high-grade B-cell lymphoma. It aims to better understand the tumor environment and how these patients respond to standard chemotherapy.
Hear when a new Follicular Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.